Working… Menu

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00079092
Recruitment Status : Completed
First Posted : March 9, 2004
Last Update Posted : April 19, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Wake Forest University Health Sciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 21, 2006
Actual Study Completion Date : March 21, 2006